Q2
SCI-Expanded Hakemli
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics
Allergy and Asthma Proceedings · 2024 · Cilt 45